story of the week
Second Primary Malignancy in Myelofibrosis Patients Treated With Ruxolitinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Second Primary Malignancy in Myelofibrosis Patients Treated With Ruxolitinib
Br. J. Haematol 2020 Nov 21;[EPub Ahead of Print], N Polverelli, EM Elli, E Abruzzese, GA Palumbo, G Benevolo, M Tiribelli, M Bonifacio, A Tieghi, G Caocci, M D'Adda, M Bergamaschi, G Binotto, FH Heidel, F Cavazzini, M Crugnola, N Pugliese, C Bosi, A Isidori, D Bartoletti, G Auteri, R Latagliata, L Gandolfi, B Martino, L Scaffidi, D Cattaneo, F D'Amore, MM Trawinska, R Stella, U Markovic, L Catani, F Pane, A Cuneo, M Krampera, G Semenzato, RM Lemoli, N Vianelli, M Breccia, D Russo, M Cavo, A Iurlo, F PalandriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.